Accessibility Menu
 
Drägerwerk Ag & KGaA logo

Drägerwerk Ag & KGaA

(OTC) DGWPF

Current Price$76.66
Market Cap$1.44B
Since IPO (2016)+30%
5 Year+4%
1 Year+77%
1 Month+6%

Drägerwerk Ag & KGaA Financials at a Glance

Market Cap

$1.44B

Revenue (TTM)

$3.48B

Net Income (TTM)

$139.53M

EPS (TTM)

$8.67

P/E Ratio

8.84

Dividend

$2.20

Beta (Volatility)

0.05 (Low)

Price

$76.66

Volume

133

Open

$76.66

Previous Close

$76.66

Daily Range

$76.66 - $76.66

52-Week Range

$55.81 - $76.66

DGWPF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Drägerwerk Ag & KGaA

Industry

Healthcare Equipment and Supplies

Employees

16,687

CEO

Stefan Dräger

Headquarters

Lübeck, 23558, DE

DGWPF Financials

Key Financial Metrics (TTM)

Gross Margin

45%

Operating Margin

7%

Net Income Margin

4%

Return on Equity

9%

Return on Capital

10%

Return on Assets

4%

Earnings Yield

11.31%

Dividend Yield

0.03%

Payout Ratio

26.86%

Stock Overview

Market Cap

$1.44B

Shares Outstanding

18.76M

Volume

133

Short Interest

0.00%

Avg. Volume

4.081

Financials (TTM)

Gross Profit

$1.51B

Operating Income

$238.19M

EBITDA

$384.69M

Operating Cash Flow

$238.24M

Capital Expenditure

$71.79M

Free Cash Flow

$166.44M

Cash & ST Invst.

$283.96M

Total Debt

$404.96M

Drägerwerk Ag & KGaA Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$1.14B

+5.8%

Gross Profit

$517.47M

+4.8%

Gross Margin

45.47%

N/A

Market Cap

$1.44B

N/A

Market Cap/Employee

$93.12K

N/A

Employees

15,444

N/A

Net Income

$94.61M

+24.4%

EBITDA

$189.24M

+80.8%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$121.00M

+17.9%

Accounts Receivable

$946.93M

+10.4%

Inventory

$635.83M

-2.8%

Long Term Debt

$293.26M

+2.2%

Short Term Debt

$111.69M

+2.8%

Return on Assets

4.26%

N/A

Return on Invested Capital

9.71%

N/A

Free Cash Flow

$118.02M

+37.4%

Operating Cash Flow

$145.62M

+32.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MDRSFMedartis Holding AG
$115.00+0.00%
LYPHFLuye Pharma Group Ltd.
$0.38+0.00%
BITGFBiotage AB (publ)
$15.01+0.00%
CMPUYCompuGroup Medical SE & Co. KGaA
$23.00-7.26%

Trending Stocks

Symbol / CompanyPricePrice Chg
SKYQSky Quarry
$5.10+1.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$11.37-0.11%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.33+0.00%
TSLATesla
$360.59-0.05%

Questions About DGWPF

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.